Salmond (second left) surrounded by BASF scientists and management. Kelliher (far right) told us: “As soon as I met BASF I knew they were the perfect home for Equateq because Equateq was a small entrepreneurial company with a break-through technology but we were very weak in other areas like support infrastructure and systems whereas they are quite the opposite.”
“We have a lot of new kit in and built up our quality systems. We were under resourced, now we are properly resourced.”
in-Pharmatechnologist.com takes a look at the People on the Move this week.
The WHO Executive Board prepares for a special Ebola meeting, CEO leaves troubled biotech, and senior staff...
Novartis's CEO becomes President of EFPIA, a new head of R&D for Genentech, and more People on...